Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The FDA Should Have Approved Probuphine, But They Didn't... So Now What?
Seeking Alpha
Friday, August 16, 2013 - 10:10am
tags:
FDA, Probuphine, Titan Pharmaceuticals, opioid addiction
Epizyme receives ophran drug designation for EPZ-5676
Yahoo/Fly on the Wall
Friday, August 16, 2013 - 10:09am
tags:
Epizyme, orphan drugs, EPZ-5676
Additional GlaxoSmithKline quadrivalent intramuscular influenza vaccine approved by FDA
Yahoo
Friday, August 16, 2013 - 9:59am
tags:
vaccines, GSK, FDA, Flulaval Quadrivalent, influenza
The hottest disease field for biotech startups and M&A might surprise you
Fierce Biotech
Friday, August 16, 2013 - 9:25am
tags:
biotech, start-ups, M&A, CNS
A Sensible Acquisition by This Healthcare Company
Motley Fool
Friday, August 16, 2013 - 9:20am
tags:
M&A, Pfizer, Medicines Company, Fibrocaps, Endo Health Solutions
A Preemptive Strike? Roche Relinquishes Its Herceptin Patent In India
Pharmalot
Friday, August 16, 2013 - 9:15am
tags:
India, patents, Roche, Herceptin
Iluvien And Tethadur: Sustained Release Treatments With Big Potential For pSivida
Seeking Alpha
Friday, August 16, 2013 - 9:13am
tags:
Iluvien, Tethadur, pSivida, Alimera, posterior uveitis, DME
Arena Approaches 50% Institutional Ownership
Seeking Alpha
Thursday, August 15, 2013 - 2:53pm
tags:
Arena Pharmaceuticals, Vivus, Orexigen, Belviq, Contrave, Qsymia
Our BioPharma Catalyst Watch List
Seeking Alpha
Thursday, August 15, 2013 - 12:09pm
tags:
Astex, Biodel, Insmed, MannKind, Onconova, Afrezza, Dacogen, Arikace, Rigosertib
Biotechs crowd list of top growth leaders as Big Pharmas shrink staffs
Fierce Biotech
Thursday, August 15, 2013 - 12:04pm
tags:
layoffs, hirings
Which are pharma's top 4 innovators? Hint: It's not the big guys
Fierce Pharma
Thursday, August 15, 2013 - 11:59am
tags:
innovation, Mylan, Novo Nordisk, Perrigo Company, Valeant Pharmaceuticals
NY fund trustee to continue push for exec-pay clawbacks at Abbott
Fierce Pharma
Thursday, August 15, 2013 - 11:58am
tags:
executive pay, Abbott Labs
Regeneron's CEO Talks About His Drugs For Eye Disease, Cholesterol, And Asthma Comment Now Follow Comments
Forbes
Thursday, August 15, 2013 - 11:57am
tags:
Regeneron, Pharma CEOs, Eylea, Leonard Schleifer, PCSK9 inhibitors
Novavax rallies after analyst says vaccine potential undervalued
The Fly on the Wall
Thursday, August 15, 2013 - 11:52am
tags:
Novavax, vaccines, RSV
Onyx Pharmaceuticals still likely to be acquired by Amgen, says ISI Group
Yahoo/Fly on the Wall
Thursday, August 15, 2013 - 11:50am
tags:
ONYX Pharmaceuticals, Amgen, M&A
2 Biotech Stocks That Could Be on Novartis' Buyout Radar
Motley Fool
Thursday, August 15, 2013 - 11:48am
tags:
Novartis, M&A, Biomarin, Incyte
Boehringer sales flat as world pharma market 'stagnates'
Pharma Times, UK
Thursday, August 15, 2013 - 10:46am
tags:
Boehringer Ingelheim, earnings
Quintiles to Acquire Oncology, Med Device CRO Novella Clinical
Outsourcing Pharma
Thursday, August 15, 2013 - 10:44am
tags:
Quintiles, Novella Clinical, CROs, devices, M&A
Amgen Talks to Buy Onyx Said to Stall on Drug Trial Data
Bloomberg
Thursday, August 15, 2013 - 10:40am
tags:
Amgen, ONYX Pharmaceuticals, M&A, Kyprolis
Strong Phase III Ampion Data Released Wednesday: Setting The Stage For Ampio
Seeking Alpha
Thursday, August 15, 2013 - 10:22am
tags:
Ampio Pharmaceuticals, NSAIDs, Ampion

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.